News
Maropost extends its "High Performer" streak in G2 Winter Reports while earning new "Easiest to Use" badge
Marketing Cloud reinforces mid-market excellence in marketing automation across seven categories and 71 reports.
Asia Direct Cable (ADC) International Submarine Cable Officially Launched: Bridging Asia and Supporting Regional Digital Transformation
HONG KONG,Dec. 20,2024-- On 8th November 2024,the Asia Direct Cable (ADC) international submarine cable,initiated and led by China Telecom,officially announced its commencement of operations. As a lea
China Matters' Feature: Beidahuang: Green Development on Black Soil
BEIJING,Dec. 19,2024-- Beidahuang(literally,"Great Northern Wilderness"),once a desolate land,has now become the cornerstone of China\'s food security. This vast expanse of land in Northeast
Pollo AI Launches Video-to-Video Feature, Revolutionizing Creative AI Video Creation and Outshining Competitors
SINGAPORE and NEW YORK,Dec. 20,2024-- Pollo AI,a leading AI video generator released by HIX.AI,announced the launch of an innovative video-to-video feature today. It allows users to effortlessly tran
AUM of USD 635 Billion at ADFW Caps Stellar Q4 as Trillion-Dollar Club Flock to ADGM
ABU DHABI,UAE,Dec. 20,2024-- ADGM,the leading international financial centre of Abu Dhabi and a globally recognised hub for asset and wealth management unveiled nineteen major announcements from glob
TMA Automotive Software Center Launched Solutions For Software-Defined Vehicles
HO CHI MINH CITY,Vietnam,Dec. 20,2024-- After several years of intensive investment on R&D,TMA Automotive Software Center has completed a set of new solutions to support development of Software-De
DEMATIC STRENGTHENS PRESENCE IN TAIWAN WITH NEW OFFICE OPENING IN TAOYUAN CITY
TAOYUAN,Dec. 18,2024--Dematic,a leading automated solution provider globally and in Asia Pacific,has announced the opening of its new office in Taiwan. This strategic expansion further solidifies Dema
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study,ASC47 low dose combination 1 (ASC47,3 mg/kg,subcutaneous (SQ),once every four weeks plus semaglutide,30 nmol/kg,SQ,once daily),demonstrated super
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production
SHANGHAI,Dec. 18,2024-- ShanghaiJuncell Therapeutics Co.,Ltd. (Juncell Therapeutics),a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies,annou
China's First Factory-Based Seawater Hydrogen Production Project Completed at Sinopec Qingdao Refinery
QINGDAO,China,Dec. 19,2024-- China Petroleum & Chemical Corporation\'s (HKG: 0386,"Sinopec") completes China\'s first factory-based seawater hydrogen production research project at its